BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 22901846)

  • 1. Gonadotropin-releasing hormone (GnRH) agonist leuprolide acetate and GnRH antagonist cetrorelix acetate directly inhibit leiomyoma extracellular matrix production.
    Britten JL; Malik M; Levy G; Mendoza M; Catherino WH
    Fertil Steril; 2012 Nov; 98(5):1299-307. PubMed ID: 22901846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadotropin-releasing hormone analogues inhibit leiomyoma extracellular matrix despite presence of gonadal hormones.
    Malik M; Britten J; Cox J; Patel A; Catherino WH
    Fertil Steril; 2016 Jan; 105(1):214-24. PubMed ID: 26409322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadotropin-releasing hormone agonist increases expression of osmotic response genes in leiomyoma cells.
    McCarthy-Keith DM; Malik M; Britten J; Segars J; Catherino WH
    Fertil Steril; 2011 Jun; 95(7):2383-7. PubMed ID: 21496801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mifepristone inhibits extracellular matrix formation in uterine leiomyoma.
    Patel A; Malik M; Britten J; Cox J; Catherino WH
    Fertil Steril; 2016 Apr; 105(4):1102-10. PubMed ID: 26776909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tranilast, an orally active antiallergic compound, inhibits extracellular matrix production in human uterine leiomyoma and myometrial cells.
    Islam MS; Protic O; Ciavattini A; Giannubilo SR; Tranquilli AL; Catherino WH; Castellucci M; Ciarmela P
    Fertil Steril; 2014 Aug; 102(2):597-606. PubMed ID: 24934492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotropin-releasing hormone antagonist cetrorelix down-regulates proliferating cell nuclear antigen and epidermal growth factor expression and up-regulates apoptosis in association with enhanced poly(adenosine 5'-diphosphate-ribose) polymerase expression in cultured human leiomyoma cells.
    Chen W; Yoshida S; Ohara N; Matsuo H; Morizane M; Maruo T
    J Clin Endocrinol Metab; 2005 Feb; 90(2):884-92. PubMed ID: 15536154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leiomyoma fibrosis inhibited by liarozole, a retinoic acid metabolic blocking agent.
    Gilden M; Malik M; Britten J; Delgado T; Levy G; Catherino WH
    Fertil Steril; 2012 Dec; 98(6):1557-62. PubMed ID: 22925684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of leuprolide and cetrorelix on cell growth, apoptosis, and GnRH receptor expression in primary cell cultures from human prostate carcinoma.
    Castellón E; Clementi M; Hitschfeld C; Sánchez C; Benítez D; Sáenz L; Contreras H; Huidobro C
    Cancer Invest; 2006; 24(3):261-8. PubMed ID: 16809153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cetrorelix, a gonadotropin-releasing hormone antagonist, induces the expression of melatonin receptor 1a in the gonadotropin-releasing hormone neuronal cell line GT1-7.
    Ishii H; Sato S; Yin C; Sakuma Y; Kato M
    Neuroendocrinology; 2009; 90(3):251-9. PubMed ID: 19641296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Luteinizing hormone-releasing hormone agonist triptorelin and antagonist cetrorelix inhibit EGF-induced c-fos expression in human gynecological cancers.
    Gründker C; Völker P; Schulz KD; Emons G
    Gynecol Oncol; 2000 Aug; 78(2):194-202. PubMed ID: 10926802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro.
    Chegini N; Rong H; Dou Q; Kipersztok S; Williams RS
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3215-21. PubMed ID: 8784072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liarozole inhibits transforming growth factor-β3--mediated extracellular matrix formation in human three-dimensional leiomyoma cultures.
    Levy G; Malik M; Britten J; Gilden M; Segars J; Catherino WH
    Fertil Steril; 2014 Jul; 102(1):272-281.e2. PubMed ID: 24825427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a three-dimensional in vitro model for uterine leiomyoma and patient-matched myometrium.
    Malik M; Catherino WH
    Fertil Steril; 2012 Jun; 97(6):1287-93. PubMed ID: 22425196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell proliferation effect of GnRH agonist on pathological lesions of women with endometriosis, adenomyosis and uterine myoma.
    Khan KN; Kitajima M; Hiraki K; Fujishita A; Nakashima M; Ishimaru T; Masuzaki H
    Hum Reprod; 2010 Nov; 25(11):2878-90. PubMed ID: 20829343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of cetrorelix, a GnRH antagonist, and leuprolide, a GnRH agonist, on experimental endometriosis.
    Altintas D; Kokcu A; Tosun M; Cetinkaya MB; Kandemir B
    J Obstet Gynaecol Res; 2008 Dec; 34(6):1014-9. PubMed ID: 19012701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of in situ expression of aromatase P450 in leiomyoma of the uterus by leuprorelin acetate.
    Shozu M; Sumitani H; Segawa T; Yang HJ; Murakami K; Inoue M
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5405-11. PubMed ID: 11701714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of GnRH analogs on the expression of TrkA and p75 neurotrophin receptors in primary cell cultures from human prostate adenocarcinoma.
    Sánchez C; Clementi M; Benitez D; Contreras H; Huidobro C; Castellón E
    Prostate; 2005 Nov; 65(3):195-202. PubMed ID: 15948150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in proliferating and apoptotic markers of leiomyoma following treatment with a selective progesterone receptor modulator or gonadotropin-releasing hormone agonist.
    Yun BS; Seong SJ; Cha DH; Kim JY; Kim ML; Shim JY; Park JE
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():62-7. PubMed ID: 26093349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myometrial cells undergo fibrotic transformation under the influence of transforming growth factor beta-3.
    Joseph DS; Malik M; Nurudeen S; Catherino WH
    Fertil Steril; 2010 Mar; 93(5):1500-8. PubMed ID: 19328471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leuprolide acetate-treated leiomyomas retain their relative overexpression of collagen type I and collagen type III messenger ribonucleic acid.
    Stewart EA; Rhoades AR; Nowak RA
    J Soc Gynecol Investig; 1998; 5(1):44-7. PubMed ID: 9501298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.